Aster Capital Management (Difc) LTD Recursion Pharmaceuticals, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 1,263 shares of RXRX stock, worth $7,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,263Holding current value
$7,540% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
341Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$203 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$193 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$148 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$103 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$87.6 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.08B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...